Arsad, Shyra B.
HRN: 20-36-65 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFUROXIME 1.5GM (VIAL)
06/16/2022
06/16/2022
IVT
1.5g
Loading Dose On Call To OR
G2P1 (1001) Incomplete Abortion For Stat Dilation And Curettage
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary TractReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes